At the center of our portfolio stand medicines designed to treat type 2 diabetes and complications accompanying this disease. We also offer medicines for the treatment of opioid-induced constipation, breakthrough pain and the treatment and prophylaxis of thromboembolic disease.



Medicine from the group of peripherally acting µ-opioid receptor antagonists in the gastrointestinal tract, reducing the constipation effects of opioids without affecting their analgesic effect on the central nervous system, treatment of opioid-induced constipation, in the form of tablets.